Preethi Ravindranathan

2.0k total citations
18 papers, 1.0k citations indexed

About

Preethi Ravindranathan is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Preethi Ravindranathan has authored 18 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Pulmonary and Respiratory Medicine and 5 papers in Oncology. Recurrent topics in Preethi Ravindranathan's work include Prostate Cancer Treatment and Research (6 papers), Estrogen and related hormone effects (5 papers) and Cancer, Lipids, and Metabolism (3 papers). Preethi Ravindranathan is often cited by papers focused on Prostate Cancer Treatment and Research (6 papers), Estrogen and related hormone effects (5 papers) and Cancer, Lipids, and Metabolism (3 papers). Preethi Ravindranathan collaborates with scholars based in United States, Australia and China. Preethi Ravindranathan's co-authors include Ajay Goel, Ganesh V. Raj, Shusuke Toden, Haiyong Han, Kazuhiro Yoshida, Jer‐Tsong Hsieh, Jinghua Gu, Jacob Cardenas, Jung‐Mo Ahn and Tae-Kyung Lee and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Oncogene.

In The Last Decade

Preethi Ravindranathan

17 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Preethi Ravindranathan United States 14 560 263 256 241 199 18 1.0k
Ramadevi Subramani United States 21 631 1.1× 303 1.2× 372 1.5× 75 0.3× 95 0.5× 32 1.0k
Rajnee Kanwal United States 14 973 1.7× 166 0.6× 372 1.5× 147 0.6× 94 0.5× 24 1.3k
Wenbin Song China 19 540 1.0× 245 0.9× 213 0.8× 204 0.8× 74 0.4× 36 985
Yanqing Li China 25 1.2k 2.1× 399 1.5× 748 2.9× 469 1.9× 72 0.4× 104 1.9k
Sharad Khare United States 23 761 1.4× 571 2.2× 246 1.0× 122 0.5× 216 1.1× 52 1.6k
Narazah Mohd Yusoff Malaysia 17 448 0.8× 244 0.9× 176 0.7× 139 0.6× 70 0.4× 79 1.0k
Guangjuan Zheng China 23 588 1.1× 255 1.0× 290 1.1× 196 0.8× 22 0.1× 59 1.3k
Szu‐Ting Lin Taiwan 20 475 0.8× 191 0.7× 111 0.4× 79 0.3× 57 0.3× 38 953
Aruna S. Jaiswal United States 23 1.2k 2.1× 485 1.8× 292 1.1× 84 0.3× 121 0.6× 51 1.5k
Serena Veschi Italy 21 480 0.9× 345 1.3× 266 1.0× 74 0.3× 200 1.0× 51 1.1k

Countries citing papers authored by Preethi Ravindranathan

Since Specialization
Citations

This map shows the geographic impact of Preethi Ravindranathan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Preethi Ravindranathan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Preethi Ravindranathan more than expected).

Fields of papers citing papers by Preethi Ravindranathan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Preethi Ravindranathan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Preethi Ravindranathan. The network helps show where Preethi Ravindranathan may publish in the future.

Co-authorship network of co-authors of Preethi Ravindranathan

This figure shows the co-authorship network connecting the top 25 collaborators of Preethi Ravindranathan. A scholar is included among the top collaborators of Preethi Ravindranathan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Preethi Ravindranathan. Preethi Ravindranathan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Agarwala, Anandita, Priyanka Satish, Preethi Ravindranathan, et al.. (2024). Cardiovascular Disease Risk in South Asians in the Baylor Scott and White Health DILWALE Registry. JACC Advances. 3(12). 101349–101349. 1 indexed citations
2.
Al‐Azizi, Karim, Chadi Dib, Sameh Sayfo, et al.. (2023). Distal Versus Proximal Radial Artery Access for Cardiac Catheterization: 30‐Day Outcomes of the DIPRA Study. Journal of the American Heart Association. 12(21). e030774–e030774. 10 indexed citations
3.
Lee, Tae-Kyung, Preethi Ravindranathan, Rajni Sonavane, Ganesh V. Raj, & Jung‐Mo Ahn. (2019). A Structure—Activity Relationship Study of Bis-Benzamides as Inhibitors of Androgen Receptor—Coactivator Interaction. Molecules. 24(15). 2783–2783. 6 indexed citations
4.
Toden, Shusuke, et al.. (2018). Oligomeric proanthocyanidins (OPCs) target cancer stem-like cells and suppress tumor organoid formation in colorectal cancer. Scientific Reports. 8(1). 3335–3335. 63 indexed citations
5.
Ravindranathan, Preethi, Uthra Balaji, Jacob Cardenas, et al.. (2018). A combination of curcumin and oligomeric proanthocyanidins offer superior anti-tumorigenic properties in colorectal cancer. Scientific Reports. 8(1). 13869–13869. 58 indexed citations
6.
Centenera, Margaret M., Theresa E. Hickey, Shalini Jindal, et al.. (2018). A patient‐derived explant (PDE) model of hormone‐dependent cancer. Molecular Oncology. 12(9). 1608–1622. 85 indexed citations
8.
Ravindranathan, Preethi, Uthra Balaji, Jacob Cardenas, et al.. (2018). Mechanistic insights into anticancer properties of oligomeric proanthocyanidins from grape seeds in colorectal cancer. Carcinogenesis. 39(6). 767–777. 46 indexed citations
9.
Yoshida, Kazuhiro, Shusuke Toden, Preethi Ravindranathan, Haiyong Han, & Ajay Goel. (2017). Curcumin sensitizes pancreatic cancer cells to gemcitabine by attenuating PRC2 subunit EZH2, and the lncRNA PVT1 expression. Carcinogenesis. 38(10). 1036–1046. 172 indexed citations
10.
Clister, Terri, John A. Shupe, Preethi Ravindranathan, et al.. (2015). Mouse Spermatogenesis Requires Classical and Nonclassical Testosterone Signaling1. Biology of Reproduction. 94(1). 11–11. 81 indexed citations
11.
Brand, Lucas J., Margaret E. Olson, Preethi Ravindranathan, et al.. (2015). EPI-001 is a selective peroxisome proliferator-activated receptor-gamma modulator with inhibitory effects on androgen receptor expression and activity in prostate cancer. Oncotarget. 6(6). 3811–3824. 58 indexed citations
12.
Ravindranathan, Preethi, Carol A. Lange, & Ganesh V. Raj. (2015). Minireview: Deciphering the Cellular Functions of PELP1. Molecular Endocrinology. 29(9). 1222–1229. 21 indexed citations
14.
Gonugunta, Vijay K., Miao Lu, Gangadhara R. Sareddy, et al.. (2014). The social network of PELP1 and its implications in breast and prostate cancers. Endocrine Related Cancer. 21(4). T79–T86. 18 indexed citations
15.
Daniel, Andrea R., Todd P. Knutson, Julie H. Ostrander, et al.. (2014). Progesterone receptor-B enhances estrogen responsiveness of breast cancer cells via scaffolding PELP1- and estrogen receptor-containing transcription complexes. Oncogene. 34(4). 506–515. 107 indexed citations
16.
Wang, Shan, Rahul K. Kollipara, Nishi Srivastava, et al.. (2014). Ablation of the oncogenic transcription factor ERG by deubiquitinase inhibition in prostate cancer. Proceedings of the National Academy of Sciences. 111(11). 4251–4256. 103 indexed citations
17.
Ravindranathan, Preethi, Tae-Kyung Lee, Lin Yang, et al.. (2013). Peptidomimetic targeting of critical androgen receptor–coregulator interactions in prostate cancer. Nature Communications. 4(1). 1923–1923. 130 indexed citations
18.
Yang, Lin, Preethi Ravindranathan, Payal Kapur, et al.. (2012). Central Role for PELP1 in Nonandrogenic Activation of the Androgen Receptor in Prostate Cancer. Molecular Endocrinology. 26(4). 550–561. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026